Chandrasekar AP, Cummins NW, Natesampillai S, Misra A, et al. The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model. J Virol 2022 Nov 30:e0173022. doi: 10.1128/jvi.01730.
PMID: 36448802